Chang JC, Harrington AM, Olteanu H, VanTuinen P, Kroft SH.
Proliferation centers in bone marrows involved by chronic lymphocytic leukemia/small lymphocytic lymphoma: a clinicopathologic analysis.Ann Diagn Pathol 2016 Dec;25:15-19
Harrington AM, Schelling LA, Ordobazari A, Olteanu H, Hosking PR, Kroft SH.
Immunophenotypes of Chronic Myelomonocytic Leukemia (CMML) Subtypes by Flow Cytometry: A Comparison of CMML-1 vs CMML-2, Myeloproliferative vs Dysplastic, De Novo vs Therapy-Related, and CMML-Specific Cytogenetic Risk Subtypes.Am J Clin Pathol 2016 Aug;146(2):170-81
Li H, Hasserjian RP, Kroft SH, Harrington AM, Wheaton SE, Pildain A, Ewalt MD, Gratzinger D, Hosking P, Olteanu H.
Pure Erythroid Leukemia and Erythroblastic Sarcoma Evolving From Chronic Myeloid Neoplasms.Am J Clin Pathol 2016 Apr;145(4):538-51
Cogbill CH, Spears MD, Vantuinen P, Harrington AM, Olteanu H, Kroft SH.
Morphologic and cytogenetic variables affect the flow cytometric recovery of plasma cell myeloma cells in bone marrow aspirates.Int J Lab Hematol 2015 Dec;37(6):797-808
Olteanu H, Harrington AM, Kroft SH.
CD200 expression in plasma cells of nonmyeloma immunoproliferative disorders: clinicopathologic features and comparison with plasma cell myeloma.Am J Clin Pathol 2012 ;2(2):128-35
Olteanu H, Schur BC, Harrington AM, Kroft SH.
Time and temperature stability of T-cell subsets evaluated by a dual-platform method.Am J Blood Res 2012 ;2(2):128-35
